Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer

Clinical and Translational Oncology

Volumn 14, Issue 11, 2012, Pages 848-852

  Song, Shi Peng ^a,b   Zhang, Sheng Bin ^a,b   Li, Zhe Hai ^a   Zhou, Yong Sheng ^a   Li, Bing ^a   Bian, Zhan Wei ^c   Liao, Qian De ^a   Zhang, Yang De ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL COLLEGE   (China)

^c Hospital of Jiuyuan Baotou   (China)

Author keywords

Immunohistochemistry; Pancreatic cancer; Prognosis; Raf kinase inhibitory protein

Indexed keywords

PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PANCREAS CANCER; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY;

AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84871202034     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0870-7     Document Type: Article

References (17)

1. Hong SM, Li A, Olino K et al (2011) Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas. Mod Pathol 24:1237-1247
2. Mancuso A, Sacchetta S, Saletti PC et al (2010) Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey. Anticancer Res 30:4289-4295
3. Baritaki S, Katsman A, Chatterjee D et al (2007) Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol 179:5441-5453
4. Tang H, Park S, Sun SC et al (2010) RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett 584:662-668
5. Wu K, Bonavida B (2009) The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 29:241-254
6. Khamis ZI, Iczkowski KA, Sang QX. (2011) Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev, in press
7. Li HZ, Gao Y, Zhao XL et al (2009) Effects of Raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7:832-840
8. Zaravinos A, Kanellou P, Baritaki S et al (2009) BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma. Cell Cycle 8:1402-1408
9. Kim HS, Kim GY, Lim SJ et al (2010) Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma. Hum Pathol 41:1609-1616
10. Xu YF, Yi Y, Qiu SJ et al (2010) PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol 53:872-879
11. Zlobec I, Baker K, Minoo P et al (2008) Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 14:143-148
12. Li HZ, Wang Y, Gao Y et al (2008) Effects of Raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 6:917-928
13. Sobin LH, Fleming ID (1997) TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80:1803-1804
14. Al-Mulla F, Hagan S, Al-Ali W et al (2008) Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol 61:524-529
15. Klysik J, Theroux SJ, Sedivy JM et al (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 20:1-9
16. Ruan L, Wang GL, Yi H et al (2010) Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110:975-981
17. Hayashi E, Kuramitsu Y, Okada F et al (2005) Proteomic profiling for cancer progression: differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. Proteomics 5:1024-1032